Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Singlet Oxygen Quantification After UVA Exposure
NCT05865431Completed
- Sponsor
- University of California, Davis
- Start
- Mar 2017
- Primary completion
- Feb 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label trial of avobenzone and zinc oxide in photoaging, sponsored by University of California, Davis. Primary endpoints: Amount of singlet oxygen generated by the left forearm skin after exposure to UVA radiation dose of 0.33 J/cm2 at 5 minutes, Amount of singlet oxygen generated by the left forearm skin after exposure to UVA radiation dose of 8.25 J/cm2 at 5 minutes and 1 more. Started Mar 2017; status: completed.
02
Drugs
avobenzonezinc oxide
03
Conditions
photoaging
Beyond the preview
Go deeper on NCT05865431.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05865431.